Genreral Announcement pertaining to disclosure of Ultimate Benificial Owners (UBOs) of Proposed Allottees in connection with the Extra-Ordinary General Meeting (EGM) held on October 22, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has submitted a detailed list of Ultimate Beneficial Owners (UBOs) for the allottees in its preferential allotment of Equity Shares and Warrants, approved at the EGM held on October 22, 2025. The 18 proposed allottees include institutional investors, family trusts, HUFs, and private companies such as Alchemy Capital Management, Capri Global Holdings, NAV Capital VCC, and several others. Notably, the Estate of Late Shri. Rakesh Jhunjhunwala (via Rekha Jhunjhunwala) is listed as a UBO through Alchemy Capital Management. The company clarified this disclosure supersedes earlier UBO details but does not change the terms, pricing, or resolutions of the original preferential allotment.
This is a procedural/compliance disclosure and does not change the terms of the preferential allotment. The involvement of a marquee investor linked to the Jhunjhunwala family may be seen positively by the market, but no pricing details or new financial information is provided here.